REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Yuhan Corporation (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Yuhan Corporation Profile Updated: March 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Yuhan Corporation is engaged in manufacturing pharmaceutical products used for treating inflammatory, autoimmune, oncologic and metabolic diseases. The company offers antivirals (HCV and HIV), antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds, among others. Yuhan Corporation is based in Seoul, South Korea. The company was incorporated in 1936.

Headquarters
49-6 Daebang-Dong, Dongjahk-Gu
Seoul; Seoul; Postal Code: 156-754

Contact Details: Purchase the Yuhan Corporation report to view the information.

Website: http://www.yuhan.co.kr

Basic Information
Total Employees:
Purchase the Yuhan Corporation report to view the information.
Outstanding Shares:
Purchase the Yuhan Corporation report to view the information.
Registered Capital:
Purchase the Yuhan Corporation report to view the information.
Financial Auditors:
Purchase the Yuhan Corporation report to view the information.
Incorporation Date:
1936
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
0.07%
Purchase this report to view the information.
0.02%
Subsidiaries
Yuhan Anz Pty Ltd
Yuhan Hong Kong Limited
Yuhan Usa Corporation
Company Performance
Financial values in the chart are available after Yuhan Corporation report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
4.68%▲
Total operating revenue
6.61%▲
Operating profit (EBIT)
82.43%▲
EBITDA
44.97%▲
Net Profit (Loss) for the Period
47.95%▲
Total assets
13.8%▲
Total equity
4.68%▲
Operating Profit Margin (ROS)
2.88%▲
Net Profit Margin
2.11%▲
Return on Equity (ROE)
1.87%▲
Debt to Equity Ratio
6.1%▲
Quick Ratio
-0.44%▼
Cash Ratio
-0.16%▼

Similar companies

Cj Cheiljedang Corporation
 
SK Discovery Co.,Ltd.
Kt&G Corporation
 
Amore Pacific Group
Samsung Biologics Co., Ltd.
 
Green Cross Holdings Corporation
Green Cross Corporation
 
Daewoong Co.,Ltd.
Chong Kun Dang Pharmaceutical Corp.
 
Kwang Dong Pharmaceutical Co.,Ltd.
Hanmi Pharm. Co.,Ltd.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo